COYA
Price
$5.47
Change
-$0.08 (-1.44%)
Updated
Dec 26 closing price
Capitalization
114.46M
87 days until earnings call
Intraday BUY SELL Signals
SNDX
Price
$21.30
Change
-$0.30 (-1.39%)
Updated
Dec 26 closing price
Capitalization
1.85B
72 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COYA vs SNDX

Header iconCOYA vs SNDX Comparison
Open Charts COYA vs SNDXBanner chart's image
Coya Therapeutics
Price$5.47
Change-$0.08 (-1.44%)
Volume$89.02K
Capitalization114.46M
Syndax Pharmaceuticals
Price$21.30
Change-$0.30 (-1.39%)
Volume$906.16K
Capitalization1.85B
COYA vs SNDX Comparison Chart in %
COYA
Daily Signal:
Gain/Loss:
SNDX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
COYA vs. SNDX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COYA is a StrongBuy and SNDX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (COYA: $5.47 vs. SNDX: $21.30)
Brand notoriety: COYA and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COYA: 38% vs. SNDX: 34%
Market capitalization -- COYA: $114.46M vs. SNDX: $1.85B
COYA [@Biotechnology] is valued at $114.46M. SNDX’s [@Biotechnology] market capitalization is $1.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COYA’s FA Score shows that 0 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • COYA’s FA Score: 0 green, 5 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, SNDX is a better buy in the long-term than COYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COYA’s TA Score shows that 6 TA indicator(s) are bullish while SNDX’s TA Score has 3 bullish TA indicator(s).

  • COYA’s TA Score: 6 bullish, 4 bearish.
  • SNDX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, COYA is a better buy in the short-term than SNDX.

Price Growth

COYA (@Biotechnology) experienced а -0.36% price change this week, while SNDX (@Biotechnology) price change was +2.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Reported Earning Dates

COYA is expected to report earnings on Mar 24, 2026.

SNDX is expected to report earnings on Mar 09, 2026.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDX($1.85B) has a higher market cap than COYA($114M). SNDX YTD gains are higher at: 61.120 vs. COYA (-4.538). COYA has higher annual earnings (EBITDA): -20.58M vs. SNDX (-282.58M). SNDX has more cash in the bank: 454M vs. COYA (28.1M). SNDX has higher revenues than COYA: SNDX (111M) vs COYA (3.99M).
COYASNDXCOYA / SNDX
Capitalization114M1.85B6%
EBITDA-20.58M-282.58M7%
Gain YTD-4.53861.120-7%
P/E RatioN/AN/A-
Revenue3.99M111M4%
Total Cash28.1M454M6%
Total DebtN/A1.52M-
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COYASNDX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
Bearish Trend 1 day ago
77%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
COYA
Daily Signal:
Gain/Loss:
SNDX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRKCX7.190.02
+0.28%
PGIM Real Estate Income C
JHASX10.900.01
+0.09%
JHancock Multi-Asset Absolute Return R6
FFNIX14.44N/A
N/A
Fidelity Advisor Asset Manager 40% I
FGIKX70.23N/A
N/A
Fidelity Growth & Income K
RSEYX13.54-0.01
-0.07%
Columbia Global Value Inst2

COYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, COYA has been loosely correlated with KNSA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if COYA jumps, then KNSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
-1.44%
KNSA - COYA
42%
Loosely correlated
-1.15%
GANX - COYA
38%
Loosely correlated
-2.17%
ATXS - COYA
35%
Loosely correlated
-0.23%
BCRX - COYA
32%
Poorly correlated
-0.91%
SNDX - COYA
31%
Poorly correlated
-1.39%
More

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with REPL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
-1.39%
REPL - SNDX
51%
Loosely correlated
-1.29%
KURA - SNDX
51%
Loosely correlated
-3.89%
IDYA - SNDX
46%
Loosely correlated
-1.35%
XENE - SNDX
46%
Loosely correlated
-0.38%
VCYT - SNDX
45%
Loosely correlated
-0.65%
More